n Vitro Effects of the New Calcium Antagonist Lacidipine

The Japanese Journal of Pharmacology

Volumn 62, Issue 3, 1993, Pages 289-296

  Kawada, Tomie ^a   Sun, Hsiao Tung ^a   Nakazawa, Mikio ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Cardiac muscle; diethyl 4 2 3 ( ) l,1 dimethylethoxy) 3 ; Lacidipine; Nifedipine; Organ selectivity; Vascular smooth muscle

Indexed keywords

CALCIUM ANTAGONIST; LACIDIPINE; NIFEDIPINE; POTASSIUM ION;

ACTION POTENTIAL; ANIMAL TISSUE; AORTA; ARTICLE; BASILAR ARTERY; CALCIUM ANTAGONISM; CHRONOTROPISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DOSE TIME EFFECT RELATION; FEMALE; GUINEA PIG; HEART LEFT ATRIUM; HEART PAPILLARY MUSCLE; HEART RIGHT ATRIUM; HYPERTENSION; INOTROPISM; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE;

ANIMAL; AORTA; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERIES; COMPARATIVE STUDY; DIHYDROPYRIDINES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HEART ATRIUM; HEART RATE; IN VITRO; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; NIFEDIPINE; PAPILLARY MUSCLES; POTASSIUM;

EID: 0027234761     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.62.289     Document Type: Article

References (26)

1. Carpi, C., Gaviraghi, G. and Semeraro, C.; GX 1048 (GR 43659X), a new dihydropyridine calcium antagonist with potent and long-lasting antihypertensive action. Br. J. Pharmacol. 89, Supp. 758 P (1986)
2. Micheli, D., Collodel, A., Semeraro, C., Gaviraghi, G. and Carpi, C.: Lacidipine: A calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. J. Cardiovasc. Pharmacol. 15, 666-675 (1990)
3. Pappano, A.J.: Calcium-dependent action potentials produced by catecholamine in guinea pig atrial muscle fibers depolarized by potassium. Circ. Res. 27, 379-390 (1970)
4. Shimizu, K., Ohta, T. and Toda, N.: Evidence for greater sus-ceptibihty of isolated dog cerebral arteries to Ca antagonists than peripheral arteries. Stroke 11, 261-266 (1980)
5. Taira, N.: Differences between dihydropyridine and non-dihydropyridine calcium antagonists in inotropic, chronotropic, dromotropic and vascular effects: Differences in underlying mechanism. In Bayer Symposium I.X., Cardiovascular Effects of Dihydropyridine-Type Calcium Antagonists and Agonists, Edited by Fleckenstein, A., Van Breemen, C. and Hoffmeister, F., pp. 370-378, Springer-Verlag, Berlin (1985)
6. Wada, Y., Satoh, K. and Taira, N.: Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations. J. Cardiovasc. Pharmacol. 6, 881-887 (1984)
7. Nakaya, H., Hattori, Y., Nakao, Y. and Kanno, M.: Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists. Eur. J. Pharmacol. 146, 35-43 (1988)
8. Nakayama, K. and Kasuya, Y.: Selective abolition of Ca-de-pendent responses of smooth and cardiac muscles by flunarizine. Japan. J. Pharmacol. 30, 731-742 (1980)
9. Cerbai, E., Cavalcab6, P.D., Masini, L. Visentin, S., Giotti, A. and Mugelli, A.; Cardiac electrophysiologic effects of a new calcium antagonist, lacidipine. J. Cardiovasc. Pharmacol. 15, 604-609 (1990)
10. Nabata, H.: Effects of calcium-antagonistic coronary vasodilator on myocardial contractility and membrane potentials. Japan. J. Pharmacol. 27, 239-249 (1977)
11. Fox, A.P., Now'ycky, M.C. and Tsien, R.W.: Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones. J. Physiol. (Lond.) 394, 149-172 (1987)
12. Marsh, J.D., Loh, E., Lachance, D., Barry, W.H. and Smith, T.W.: Relationship of binding of a calcium channel blocker to Inhibition of contraction in intact cultured embryonic chick ventricular cells. Circ. Res. 53, 539-543 (1983)
13. Godfraind, T.: Analysis of factors involved in the tissue selectivity of calcium antagonists. Adv. Exp. Med. Biol. 311, 103-122 (1992)
14. Fozzard, H.A.: Mechanisms of pharmacologic intervention at the level of the calcium channel. Am. J. Cardiol. 69, 4D-lOD (1992)
15. Bean, B.P.: Nitrendipine block of cardiac calcium channels: High-afffnity binding to the inactivated state. Proc. Natl. Acad. Sci. U.S.A. 81, 6388-6392 (1984)
16. Green, F.J., Farmer, B.B., Wiseman, G.L., Jose, M.J.L. and Watanabe, A.M.: Effect of membrane depolarization on binding of [3H]nitrendipine to rat cardiac myocytes. Circ. Res. 56, 576-585 (1985)
17. Morel, N. and Godfraind, T.: Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 340, 442-451 (1989)
18. Werner, G., Klaus, W., Kojda, G. and Fricke, U.; Hydrophobic properties of novel dihydronaphthyridine calcium antagonist and biological activity in porcine isolated cardiac and vascular smooth muscle. Arch. Pharmacol. 344, 337-344 (1991)
19. Tsien, R.W., Ellinor, P.T. and Horn, W.A.: Molecular diversity of voltage-dependent Ca2+ channels. Trends Pharmacol. Sci. 12, 349-354 (1991)
20. McKenna, E., Koch, W.J., Slish, D.F. and Schwartz, A.; Towards an understanding of the dihydropyridine-sensitive calcium channel. Biochem. Pharmacol. 39, 1145-1150 (1990)
21. Cristofori, P., Terron, A., Micheli, D., Bertolini, G., Gaviraghi, G. and Carpi, C.: Vascular protection of lacidipine in salt-loaded Dahl-S rats at nonsustained antihypertensive doses. J. Cardiovasc. Pharmacol. 17, Supp. 4, S75-S86 (1991)
22. Micheli, D., Ratti, E., Toson, G. and Gaviraghi, G.: Pharmacology of lacidipine, a vascular-selective calcium antagonist. J. Cardiovasc. Pharmacol. 17, Supp. 4, S1-S8 (1991)
23. Oizumi, K., Nishino, H., Koike, H., Sada, T., Miyamoto, M. and Kimura, T.: Antihypertensive effects of CS-905, a novel dihydropyridine Ca2+ channel Blocker. Japan. J. Pharmacol. 51, 57-64 (1989)
24. Diez, I., Colom, H., Moreno, J., Obach, R., Peraire, C. and Domenech, J.; A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharmaceut. Sci. 80, 931-934 (1991)
25. Gaviraghi, G.: Lacidipine, a new 1,4-dihydropyridine calcium channel antagonist possessing a potent and long-lasting antihypertensive activity. In Trends in Medical Chemistry '88, Edited by Van der Groot, N., Domany, G., Pallos, L. and Timmerman, H., pp. 675-690, Elsevier, Amsterdam (1989)
26. Godfraind, T. and Salomone, S.: Functional interaction of lacidipine with calcium channels in vascular smooth muscle. J. Cardiovasc. Pharmacol. 18, Supp. 11, S1-S6 (1991)